Calculating correct Down’s syndrome risks

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 4, 1999, Pages 371-372

  Cuckle, Howard ^a   Sehmi, Indera ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CALCULATION; DOWN SYNDROME; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; NECK; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SERODIAGNOSIS;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 0032988460     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08277.x     Document Type: Article

References (7)

1. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancer 1998; 352: 343-346.
2. Nicolaides KH, Snijders RJM, Cuckle HS. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998; 14: 203-208.
3. Cuckle H. Antenatal screening for Down’s syndrome. Lancer 1998; 352: 1144.
4. Cuckle H. Established markers in second trimester maternal serum. Early Hum Dev 1996; 47 (Suppl): S27-S29.
5. Spencer K, Noble P, Snijders RJM, Nicolaides KH. First trimester urine free beta hCG. beta core and total oestriol in pregnancies affected by Down’s syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG. Prenat Diagn 1997; 17: 525-538.
6. Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 1997; 10: 381-386.
7. Cuckle HS, Van Lith JM. Appropriate biochemical parameters in first trimester screening for Down’s syndrome. Prenat Diagn. In Press.